Clinical Trials for Immunotherapy

Find clinical trials for immunotherapy. Discover research opportunities and treatment options in your area.

125 Active Trials Found

Showing 125 trials on this page

Page 1 of 7

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

NCT ID: NCT06734702

This clinical trial is investigating a new treatment approach for people with locally advanced non-small cell lung cancer (NSCLC) that cannot be surgically removed. The study is comparing the effec...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

NCT ID: NCT06671613

This clinical trial is looking at how a special diet that mimics fasting might work alongside immunotherapy for patients with stage IV non-small cell lung cancer (NSCLC). The main goal is to see if...

Not yet recruiting

Phase: NA Type: interventional Locations: Long Beach, California, United States, Indianapolis, Indiana, United States +3 more

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

NCT ID: NCT06738160

This clinical trial is studying a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) that has spread to the bones. The researchers want to see if using a drug call...

Not yet recruiting

Phase: PHASE2 Type: interventional

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

NCT ID: NCT05909137

This clinical trial is studying a new approach to treating advanced non-small cell lung cancer (NSCLC) that cannot be surgically removed, specifically focusing on whether it's safe to skip a part o...

Not yet recruiting

Type: observational

BRAVE Study: QL1706 + Bevacizumab + SBRT for BCLC-C HCC With PVTT or Oligometastases

NCT ID: NCT07062055

This clinical trial, called the BRAVE Study, is exploring a new treatment approach for people with advanced liver cancer (hepatocellular carcinoma) who have cancer growing into the main vein of the...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

NCT ID: NCT05862259

This clinical trial is looking at how effective and safe a type of treatment called immune checkpoint inhibitors (ICIs) is when used as the first treatment for advanced cancers, such as those in th...

Recruiting

Type: observational Locations: Chongqing, Chongqing, China

Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC

NCT ID: NCT07070713

This clinical trial is studying new treatment options for people with metastatic colorectal cancer (mCRC) that started in the left side of the colon or rectum. Specifically, it is comparing two dif...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Fuzhou, Fujian, China

The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

NCT ID: NCT07069842

This clinical trial is studying a new way to predict how well patients with advanced stomach cancer will respond to immunotherapy, a type of treatment that helps the immune system fight cancer. Res...

Recruiting

Type: observational Locations: Changzhi, Shanxi, China

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

NCT ID: NCT06903312

This clinical trial is designed to investigate whether treating the primary kidney tumor in patients with metastatic renal cell carcinoma (mRCC) who are responding well to immunotherapy can help th...

Recruiting

Phase: PHASE4 Type: interventional Locations: Roma, , Italy

SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy

NCT ID: NCT06676722

This clinical trial is studying a new treatment approach for people with a type of throat cancer called nasopharyngeal carcinoma (NPC) that has come back or spread to other parts of the body after ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Xiamen, Fujian, China

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

NCT ID: NCT07040956

This clinical trial is studying a new treatment approach for people with a type of head and neck cancer called squamous cell carcinoma that can be removed by surgery. The study will compare two tre...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chengdu, Sichuan, China

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

NCT ID: NCT06356584

This clinical trial is exploring a new treatment approach for advanced metastatic colorectal cancer (CRC), which is cancer that has spread beyond the colon and rectum. The study is testing a combin...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

NCT ID: NCT07010120

This clinical trial is looking at a new treatment approach for patients with a type of cancer called head and neck squamous cell carcinoma (HNSCC) that can be surgically removed. The study is explo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China

Phase II, Single-arm Exploratory Clinical Study of Tislelizumab Combined With Anlotinib in the Treatment of Advanced Pulmonary Pleomorphic Carcinoma

NCT ID: NCT05375734

This clinical trial is studying a combination of two treatments, tislelizumab and anlotinib, for patients with advanced pulmonary pleomorphic carcinoma, a type of lung cancer that is difficult to t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nanchang, Jiangxi, China

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

NCT ID: NCT07020247

The PALACE Study is a clinical trial looking at how effective a personalized treatment combining long-course radiotherapy and chemotherapy is for patients with locally advanced rectal cancer (LARC)...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chengdu, Sichuan, China

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

NCT ID: NCT05813418

This clinical trial is looking to identify certain markers in patients that could predict potential side effects from a type of cancer treatment called immune checkpoint inhibitors (ICPI). These tr...

Recruiting

Phase: NA Type: interventional Locations: Amiens, Picardie, France

Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer

NCT ID: NCT06848439

This clinical trial is investigating a new treatment approach for patients with advanced oral cancer, specifically stage III-IVb oral squamous cell carcinoma. The study is looking at a combination ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Nanjing, Jiangsu, China

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

NCT ID: NCT06421376

This clinical trial is studying a new treatment approach for patients with locally advanced esophageal cancer, specifically a type called esophageal squamous cell carcinoma (ESCC). The researchers ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Xinxiang, Henan, China, Anyang, Henan, China +1 more

Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy

NCT ID: NCT06985485

This clinical trial is exploring the use of immunotherapy for patients with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL) who choose not to undergo traditional chemother...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Suzhou, Jiangsu, China

Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy

NCT ID: NCT06035328

This clinical trial is studying how effective two different schedules of wheat oral immunotherapy (OIT) are for people with a wheat allergy. Specifically, it compares taking a daily dose of the tre...

Recruiting

Phase: NA Type: interventional Locations: Bangkoknoi, Bangkok, Thailand

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions